share_log

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities

Feb 28, 2023 18:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more